Negotiating partnership deals workshop

Post-conference workshop
NEGOTATING PARTNERSHIP DEALS
Benefits of attending the workshop This highly interactive workshop will allow delegates to put into practice negotiating strategies, enable them to identify problems in complicated legal documentation and come to mutually acceptable solutions. Who should attend? This workshop would be of great benefit to delegates who are new to contract formation and negotiations in the vaccines industry. It will also be of benefit to delegates that require a refresher course, to help stay up to date in this constantly developing field. Your workshop leader: Simon Portman is Partner and Head of Life Sciences Department at Hewistons. He joined in 1996 and specialised in commercial and intellectual property law, largely for life science clients in the UK, Europe and the US. He sits on the Intellectual Property Advisory Committee of the Bioindustry Association, is a member of the Eastern Region Biotechnology Initiative (ERBI) and the Oxfordshire Bioscience Network and regularly gives seminars in the UK and internationally.  He is co-author of the book “Commercial Issues for Lifescience Companies” and is currently co-writing the book “Intellectual Property: the Lifeblood of Your Company” with a colleague.
09.00	An opening presentation summarizing the key issues which arise when one is negotiating a drug development collaboration such as:- Getting to the deal and picking the right partner Confidentiality agreements, materials transfer agreements, heads of terms The allocation of roles and risk between the parties Regulatory issues The use of management committees to coordinate projects, market products, formulate patent filing and defense strategy and solve disputes Intellectual property licensing, development, ownership and enforcement Different methods of payment – royalties, milestone payments, upfront fees, equity Sanctions in the event of a breach – built-in contractual remedies, damages, injunctions, specific performance When to terminate and what happens on termination Different methods of dispute resolution – mediation, arbitration, litigation Choice of law and jurisdiction How business practices and negotiating tactics vary from country to country –Northern and Southern Europe, USA, Japan, China, Middle East
10.30	Morning coffee
11.00	Working groups Delegates will be presented with the imaginary scenario of a drug development collaboration between a large US pharmaceutical company and a smaller European biotech company. It is proposed in the scenario that the US company’s drug delivery device will be sold in combination with the European company’s vaccine and joint developmental work will be carried out to make this possible.   The delegates will be split into two groups each representing one side of the collaboration.   Each group will be given a list of the aims of the collaboration from its point of view and a copy of the proposed agreement between the parties, drafted by US pharma.   The delegates will then review the agreement, discuss it among others in their group and formulate a negotiating strategy.
13.00	Lunch
14.30	Negotiating the contract Delegates will negotiate the contract with the other side in teams.
16.00	Coffee break
16.30	Review of the negotiation and points of interest raised Once the session is completed, delegates will give a resume of what they agreed and how they felt they did in the negotiation Delegates will be given a run-down of any other pertinent issues which they may have missed
17.00	Close of workshop